Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steve Laval

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|December 2, 2010
Reverse engineering gene network identifies new dysferlin-interacting proteinsMafalda Cacciottolo, Vincenzo Belcastro, Steve Laval, et al.
Plos One|February 26, 2013
Beta-blockers, left and right ventricular function, and in-vivo calcium influx in muscular dystrophy cardiomyopathyAlison Blain, Elizabeth Greally, Steve Laval, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 17, 2007
From T-tubule to sarcolemma: damage-induced dysferlin translocation in early myogenesisLars Klinge, Steve Laval, Sharon Keers, et al.
Genesis (New York, N.Y. : 2000)|April 5, 2014
Neural crest cell-specific inactivation of Nipbl or Mau2 during mouse development results in a late onset of craniofacial defectsTerence Gordon Smith, Steve Laval, Fangli Chen, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|January 18, 2013
Heterogeneous abnormalities of in-vivo left ventricular calcium influx and function in mouse models of muscular dystrophy cardiomyopathyElizabeth Greally, Benjamin J Davison, Alison Blain, et al.
European Journal of Heart Failure|August 3, 2010
Intolerance to ß-blockade in a mouse model of δ-sarcoglycan-deficient muscular dystrophy cardiomyopathyRalf Bauer, Alison Blain, Elizabeth Greally, et al.
Plos Currents|June 22, 2013
Undiagnosed genetic muscle disease in the north of England: an in depth phenotype analysisElizabeth Harris, Steve Laval, Judith Hudson, et al.
Stem Cells and Development|June 22, 2013
Exon skipping and gene transfer restore dystrophin expression in hiPSC-cardiomyocytes harbouring DMD mutationsEmily Dick, Spandan Kalra, David Anderson, et al.
Muscle & Nerve|January 19, 2010
Dysferlin associates with the developing T-tubule system in rodent and human skeletal muscleLars Klinge, John Harris, Caroline Sewry, et al.
Human Molecular Genetics|December 27, 2011
Myofibrillar myopathy caused by a mutation in the motor domain of mouse MyHC IIbRamakrishna Kurapati, Caoimhe McKenna, Johan Lindqvist, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|December 2, 2010
Reverse engineering gene network identifies new dysferlin-interacting proteinsMafalda Cacciottolo, Vincenzo Belcastro, Steve Laval, et al.
Plos One|February 26, 2013
Beta-blockers, left and right ventricular function, and in-vivo calcium influx in muscular dystrophy cardiomyopathyAlison Blain, Elizabeth Greally, Steve Laval, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 17, 2007
From T-tubule to sarcolemma: damage-induced dysferlin translocation in early myogenesisLars Klinge, Steve Laval, Sharon Keers, et al.
Genesis (New York, N.Y. : 2000)|April 5, 2014
Neural crest cell-specific inactivation of Nipbl or Mau2 during mouse development results in a late onset of craniofacial defectsTerence Gordon Smith, Steve Laval, Fangli Chen, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|January 18, 2013
Heterogeneous abnormalities of in-vivo left ventricular calcium influx and function in mouse models of muscular dystrophy cardiomyopathyElizabeth Greally, Benjamin J Davison, Alison Blain, et al.
European Journal of Heart Failure|August 3, 2010
Intolerance to ß-blockade in a mouse model of δ-sarcoglycan-deficient muscular dystrophy cardiomyopathyRalf Bauer, Alison Blain, Elizabeth Greally, et al.
Plos Currents|June 22, 2013
Undiagnosed genetic muscle disease in the north of England: an in depth phenotype analysisElizabeth Harris, Steve Laval, Judith Hudson, et al.
Stem Cells and Development|June 22, 2013
Exon skipping and gene transfer restore dystrophin expression in hiPSC-cardiomyocytes harbouring DMD mutationsEmily Dick, Spandan Kalra, David Anderson, et al.
Muscle & Nerve|January 19, 2010
Dysferlin associates with the developing T-tubule system in rodent and human skeletal muscleLars Klinge, John Harris, Caroline Sewry, et al.
Human Molecular Genetics|December 27, 2011
Myofibrillar myopathy caused by a mutation in the motor domain of mouse MyHC IIbRamakrishna Kurapati, Caoimhe McKenna, Johan Lindqvist, et al.
Pageof 2